ImaBiotech boosts its strategic partnerships

Imabiotech, a French CRO based in Lille (France) and in Boston (USA), is expanding its range of services. This company is offering innovative imaging services and software to the pharmaceutical research sector. These services are based on histology combined to label free molecular imaging (Quantitative Mass Spectrometry Imaging, QMSI) . This technology developed by ImaBiotech provides deep understanding of drug localization and its pharmacological effects at cellular effect, thus improving in vivo drug efficacy and toxicity evaluations during preclinical and clinical stage developments. (…)

More info:

Imabiotech boosts its strategic partnerships

By: Anne-Lise Berthier

Search news